Secondary Logo

Journal Logo

Articles by Todd T. Brown

GlycA, a novel inflammatory marker, is associated with subclinical coronary disease

Tibuakuu, Martin; Fashanu, Oluwaseun E.; Zhao, Di; More

AIDS. 33(3):547-557, March 1, 2019.

Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy

Kalayjian, Robert C.; Albert, Jeffrey M.; Cremers, Serge; More

AIDS. 32(17):2517-2524, November 13, 2018.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate

Güerri-Fernández, Robert; Lerma-Chippirraz, Elisabet; Fernandez Marron, Ana; More

AIDS. 32(7):913-920, April 24, 2018.

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation

Yin, Michael T.; Chan, Ellen S.; Brown, Todd T.; More

AIDS. 31(17):2337-2344, November 13, 2017.

Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease

Iantorno, Micaela; Schär, Michael; Soleimanifard, Sahar; More

AIDS. 31(9):1281-1289, June 1st, 2017.

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

Grant, Philip M.; Kitch, Douglas; McComsey, Grace A.; More

AIDS. 30(18):2805-2813, November 28th, 2016.

Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection

Kelesidis, Theodoros; Jackson, Nicholas; McComsey, Grace A.; More

AIDS. 30(17):2625-2633, November 13th, 2016.

Effect of HIV-infection and cumulative viral load on age-related decline in grip strength

Schrack, Jennifer A.; Jacobson, Lisa P.; Althoff, Keri N.; More

AIDS. 30(17):2645-2652, November 13th, 2016.

Cardiovascular disease risk scores’ relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men

Monroe, Anne K.; Haberlen, Sabina A.; Post, Wendy S.; More

AIDS. 30(13):2075-2084, August 24th, 2016.

Differential CD4+ cell count increase and CD4+  :  CD8+ ratio normalization with maraviroc compared with tenofovir

Chan, Ellen S.; Landay, Alan L.; Brown, Todd T.; More

AIDS. 30(13):2091-2097, August 24th, 2016.

A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness

Stein, James H.; Ribaudo, Heather J.; Hodis, Howard N.; More

AIDS. 29(14):1775-1783, September 10, 2015.

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men

Ketlogetswe, Kerunne S.; Post, Wendy S.; Li, Xiuhong; More

AIDS. 28(6):901-909, March 27th, 2014.

HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection

Ng, Derek K.; Jacobson, Lisa P.; Brown, Todd T.; More

AIDS. 28(3):377-386, January 28th, 2014.

Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection

Stein, James H.; Brown, Todd T.; Ribaudo, Heather J.; More

AIDS. 27(6):929-937, March 27th, 2013.

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

McComsey, Grace A.; Kitch, Douglas; Daar, Eric S.; More

AIDS. 26(11):1371-1385, July 17th, 2012.